Last --
Change Today 0.00 / 0.00%
Volume 0.0
4144 On Other Exchanges
4144 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William Robert Keller

AgeTotal Calculated CompensationThis person is connected to 58 board members in 7 different organizations across 8 different industries.

See Board Relationships


Mr. William Robert Keller is the Founder of Keller Pharma Consultancy and has been its Principal since September 2003. Mr. Keller serves as an Executive at Roche (china) Co., Ltd. From 1994 to 2003, he served as General Manager of Roche China Ltd. and Shanghai Roche Pharmaceutical Ltd. From 1974 to 2003, he served in various positions at Roche Group in South America and Asia. He served as a Senior Consultant to the Shanghai Foreign Investment Development Board from 2003 ...

Read Full Background

Corporate Headquarters*

Room 103
Shanghai, -- --


Phone: --
Fax: --

Board Members Memberships*

Supervisor and Member of Steering Committee
Independent Director
Former Independent Director, Member of Corporate Governance & Nominating Committee and Member of Audit committee
Director, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
Independent Director, Chairman of Corporate Governance & Nominations Committee and Member of Strategy & Finance Committee


Unknown/Other Education 1972
Zurich University of Applied Sciences Winterthur

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4144:TT 70.80 TWD +0.10


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Kevin A. Lobo Chairman, Chief Executive Officer and President
Stryker Corporation
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLAND HOLDINGS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at